Announced Sat, 4 Jul · 05:20 IST
Supriya Lifescience: GM held in customs case under NDPS Act
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-14.2%1-day move
₹979.00
prior close
₹932.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7-0.7-0.6-0.7-14.2-11.6-10.5-12.6-13.4-12.8-13.6———
Up moveDown movePending
AI summary
Supriya Lifescience informed exchanges that Mr. Sreekant Sreedharan, General Manager (Sales and Marketing), has been taken into judicial custody by the Customs Special Investigation branch till July 17, 2026. The proceedings are under the NDPS Act, 1985, related to an alleged procedural lapse in a single export transaction. The company says no material impact on operations, financials, or governance.
Likely market impact
Company claims no material financial or operational impact, but negative sentiment possible due to NDPS case and key personnel detention.